Shalby Ltd

  • BSE Code : 540797
  • NSE Symbol : SHALBY
  • ISIN : INE597J01018
  • Industry :HEALTHCARE

up-arrow 139.40 -0.17(-0.12%)

Open Price ()

137.45

Prev. Close ()

139.57

Volume (No’s)

108,998

Market Cap ()

1,505.66

Low Price ()

134.21

High Price ()

140.99

 

Board Meetings

Start Date End Date Purpose
02-Feb-2026 11-Feb-2026 Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve unaudited finnancial results for the period ended December 31 2025 and other business matters Outcome of Board Meeting (As Per BSE Announcement Dated on 11.02.2026)
05-Nov-2025 13-Nov-2025 Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025. Outcome of Board Meeting (As Per BSE Announcement Dated on 13.11.2025)
05-Aug-2025 13-Aug-2025 Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve unaudited standalone and consolidated financial results for quarter ended June 30 2025 Unaudited standalone and consolidated financial results for quarter ended June 30, 2025 (As Per BSE Announcement Dated on: 13.08.2025)
20-May-2025 29-May-2025 Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve audited financial results for quarter and year ended March 31 2025 to recommend dividend if any and other matters The Directors do not recommend any dividend for the financial year 2024-25. Standalone and Consolidated Financial results for the period ended March 31, 2025. (As Per BSE Announcement Dated on :29.05.2025)
28-Jan-2025 03-Feb-2025 Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31 2024 and other business matters The Board Meeting to be held on 03/02/2025 has been revised to 03/02/2025 The Board Meeting to be held on 03/02/2025 has been revised to 03/02/2025 (As Per BSE Announcement Dated on: 28/01/2025) Unaudited Standalone and Consolidated Financial results for quarter ended December 31, 2024 (As Per Bse Announcement Dated on 03.02.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew